PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding-Reference-Cited by-同舟云学术

PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding

Published:2015-08-25 Issue:6 Volume:62 Page:1858-1869
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Kwan Raymond¹²,Chen Lu¹³,Looi Koksun¹,Tao Guo-Zhong⁴,Weerasinghe Sujith V.¹,Snider Natasha T.¹,Conti Mary Anne⁵,Adelstein Robert S.⁵,Xie Qing³,Omary M. Bishr¹²

Affiliation:

1. Departments of Molecular & Integrative Physiology and of Medicine; University of Michigan; Ann Arbor MI

2. VA Ann Arbor Healthcare System; Ann Arbor MI

3. Infectious Diseases Department; Ruijin Hospital, Shanghai Jiao Tong University Medical School; Shanghai People's Republic of China

4. Department of Surgery; Stanford University; Palo Alto CA

5. The Laboratory of Molecular Cardiology; National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda MD

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27965/fullpdf

Reference33 articles.

1. Nuclear lamin functions and disease;Butin-Israeli;Trends Genet,2012

2. Intermediate filaments: structure, dynamics, function, and disease;Fuchs;Annu Rev Biochem,1994

3. When lamins go bad: nuclear structure and disease;Schreiber;Cell,2013

4. The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases;Szeverenyi;Hum Mutat,2008

5. “IF-pathies”: a broad spectrum of intermediate filament-associated diseases;Omary;J Clin Invest,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives;International Journal of Molecular Sciences;2024-08-31

2. Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and structure-activity relationships;European Journal of Medicinal Chemistry;2024-07

3. Posttranslational modifications of keratins and their associated proteins as therapeutic targets in keratin diseases;Current Opinion in Cell Biology;2023-12

4. Recent advance of clinically approved small-molecule drugs for the treatment of myeloid leukemia;European Journal of Medicinal Chemistry;2023-12

5. Painting and dissecting Epidermolysis Bullosa Simplex-associated keratin aggregates;Journal of Dermatological Science;2023-11